Kekrops (ATH:KEKR) Is Carrying A Fair Bit Of Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We note that Kekrops S.A. (ATH:KEKR) does have debt on its balance sheet. But is this debt a concern to shareholders?

We've discovered 3 warning signs about Kekrops. View them for free.
Advertisement

Why Does Debt Bring Risk?

Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. Of course, plenty of companies use debt to fund growth, without any negative consequences. When we think about a company's use of debt, we first look at cash and debt together.

What Is Kekrops's Net Debt?

The image below, which you can click on for greater detail, shows that Kekrops had debt of €2.52m at the end of December 2024, a reduction from €5.50m over a year. However, it does have €189.6k in cash offsetting this, leading to net debt of about €2.33m.

debt-equity-history-analysis
ATSE:KEKR Debt to Equity History May 10th 2025

How Healthy Is Kekrops' Balance Sheet?

Zooming in on the latest balance sheet data, we can see that Kekrops had liabilities of €658.0k due within 12 months and liabilities of €4.73m due beyond that. Offsetting this, it had €189.6k in cash and €218.6k in receivables that were due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by €4.98m.

Since publicly traded Kekrops shares are worth a total of €25.2m, it seems unlikely that this level of liabilities would be a major threat. However, we do think it is worth keeping an eye on its balance sheet strength, as it may change over time. When analysing debt levels, the balance sheet is the obvious place to start. But you can't view debt in total isolation; since Kekrops will need earnings to service that debt. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.

View our latest analysis for Kekrops

In the last year Kekrops wasn't profitable at an EBIT level, but managed to grow its revenue by 30,301%, to €4.0m. That's virtually the hole-in-one of revenue growth!

Caveat Emptor

Despite the top line growth, Kekrops still had an earnings before interest and tax (EBIT) loss over the last year. Indeed, it lost €1.1m at the EBIT level. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. Quite frankly we think the balance sheet is far from match-fit, although it could be improved with time. Another cause for caution is that is bled €1.1m in negative free cash flow over the last twelve months. So suffice it to say we do consider the stock to be risky. There's no doubt that we learn most about debt from the balance sheet. But ultimately, every company can contain risks that exist outside of the balance sheet. We've identified 3 warning signs with Kekrops , and understanding them should be part of your investment process.

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

Valuation is complex, but we're here to simplify it.

Discover if Kekrops might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About ATSE:KEKR

Kekrops

Engages in the industry of construction, development and exploitation of real estate in Greece.

Adequate balance sheet with low risk.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.673.0% undervalued
25 users have followed this narrative
0 users have commented on this narrative
17 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.235.0% undervalued
52 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2687.2% undervalued
33 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3412.8% undervalued
5 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.886.0% undervalued
76 users have followed this narrative
7 users have commented on this narrative
1 users have liked this narrative
FA
PMCK logo
FA_Trader on PMCK Berhad ·

Sunway Healthcare’s valuation spike may shine light on smaller healthcare names like PMCK

Fair Value:RM 0.2623.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CG
BLCO logo
CG86 on Bausch + Lomb ·

$BLCO & $COO The Silence BEFORE the AGM: A Retail Investor’s Timeline, Findings, and Opinion on SUSPICIOUS SILENCE!

Fair Value:US$39.2357.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3956.4% overvalued
51 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.235.0% undervalued
52 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3128.4% undervalued
1365 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

SP
EOSE logo
spearfishingcap on Eos Energy Enterprises ·

AI Slop

1
|
0
MA
BBW logo
manunogueira on Build-A-Bear Workshop ·

Why so high p/e?

0
|
0